Epidemiological Analysis and 2040 Projections of Atrial Fibrillation and Flutter in Asia
5 affiliations
- 1Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- 2Cardiovascular Disease Laboratory, Chongqing Medical University, Chongqing, China
- 3Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University, Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
- 4Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
- 5Medical University of Bialystok, Bialystok, Poland
Abstract
Background: Atrial fibrillation and flutter (AF/AFL) impose a substantial and growing global burden, yet comprehensive assessments focusing on Asia, accounting for regional heterogeneity, demographic drivers, and future trajectories, remain limited.
Objectives: This study aims to systematically evaluate the burden of AF/AFL across Asia from 1990 to 2021, to quantify the contributions of demographic and epidemiological drivers, and to project future trends to inform region-specific prevention strategies.
Methods: Using Global Burden of Disease 2021 data, we analyzed prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of AF/AFL across 48 Asian countries and territories. Joinpoint regression assessed temporal trends; decomposition analysis quantified contributions of population growth, aging, and epidemiological changes; and auto-regressive integrated moving average models projected burden to 2040.
Results: In 2021, Asia had 25,739,093 (95% uncertainty interval [UI]: 20,431,798-33,586,165) prevalent cases of AF/AFL, with age-standardized rate 529.04 (95% UI: 420.26-680.91) per 100,000. Southeast Asia exhibited the highest age-standardized burden, while only the high-income Asia-Pacific region showed declining trends. Although the burden on male was greater, older females were a group that could not be overlooked. Joinpoint analysis revealed a nonlinear trajectory with accelerated growth after 2014. Decomposition analysis identified population growth and aging as primary drivers. High systolic blood pressure was the leading risk factor, with high body mass index showing the most rapid increase. Projections indicate sustained rises through 2040, with particularly pronounced increases among females.
Conclusions: AF/AFL has become an increasingly severe public health challenge in Asia. Therefore, tailored prevention and control strategies should be developed according to regional characteristics to effectively alleviate its disease burden.
Related
- Global Geospatial Trends in Breast Cancer and Atrial Fibrillation/Flutter Among Older Women: Uncovering Shared Epidemiological Patterns and Etiological Links
- Trends in mortality involving atrial fibrillation/flutter and renal failure in the United States, 1999–2023 : A nationwide multiple-cause-of-death analysis
- Trends and Disparities in Respiratory Failure Mortality with Co-Listed Atrial Fibrillation and Flutter Among U.S. Adults Aged >= 65 Years, 1999 to 2024, with AAMR Forecasts Through 2035: A CDC Wonder Analysis
- Efficacy and Safety of Vernakalant for Cardioversion of Atrial Fibrillation and Flutter: A Systematic Review and Meta-Analysis
- Left Atrial Appendage Thrombus and Long-Term Clinical Outcomes in Anticoagulated Patients with Atrial Fibrillation and Atrial Flutter Referred for a Rhythm-Control Strategy: A Prospective Observational Cohort Study
BibTeX
@article{chen2026epidemiological,
title = {{Epidemiological Analysis and 2040 Projections of Atrial Fibrillation and Flutter in Asia}},
author = {Jing Chen and Shunyu Yao and Zhongshan Xiong and Linfeng Xie and Yuanzhu Li and Gregory Y.H. Lip and Bi Huang},
journal = {JACC Asia},
year = {2026},
month = aug,
doi = {10.1016/j.jacasi.2026.06.037},
url = {https://doi.org/10.1016/j.jacasi.2026.06.037},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Epidemiological Analysis and 2040 Projections of Atrial Fibrillation and Flutter in Asia
AU - Jing Chen
AU - Shunyu Yao
AU - Zhongshan Xiong
AU - Linfeng Xie
AU - Yuanzhu Li
AU - Gregory Y.H. Lip
AU - Bi Huang
PY - 2026
DA - 2026/08/20
JO - JACC Asia
DO - 10.1016/j.jacasi.2026.06.037
UR - https://doi.org/10.1016/j.jacasi.2026.06.037
AB - Background: Atrial fibrillation and flutter (AF/AFL) impose a substantial and growing global burden, yet comprehensive assessments focusing on Asia, accounting for regional heterogeneity, demographic drivers, and future trajectories, remain limited. Objectives: This study aims to systematically evaluate the burden of AF/AFL across Asia from 1990 to 2021, to quantify the contributions of demographic and epidemiological drivers, and to project future trends to inform region-specific prevention strategies. Methods: Using Global Burden of Disease 2021 data, we analyzed prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of AF/AFL across 48 Asian countries and territories. Joinpoint regression assessed temporal trends; decomposition analysis quantified contributions of population growth, aging, and epidemiological changes; and auto-regressive integrated moving average models projected burden to 2040. Results: In 2021, Asia had 25,739,093 (95% uncertainty interval [UI]: 20,431,798-33,586,165) prevalent cases of AF/AFL, with age-standardized rate 529.04 (95% UI: 420.26-680.91) per 100,000. Southeast Asia exhibited the highest age-standardized burden, while only the high-income Asia-Pacific region showed declining trends. Although the burden on male was greater, older females were a group that could not be overlooked. Joinpoint analysis revealed a nonlinear trajectory with accelerated growth after 2014. Decomposition analysis identified population growth and aging as primary drivers. High systolic blood pressure was the leading risk factor, with high body mass index showing the most rapid increase. Projections indicate sustained rises through 2040, with particularly pronounced increases among females. Conclusions: AF/AFL has become an increasingly severe public health challenge in Asia. Therefore, tailored prevention and control strategies should be developed according to regional characteristics to effectively alleviate its disease burden.
SN - 2772-3747
ER -